Skip to main content
NCBI home page
Gut logoLink to Gut
. 1994 Jun;35(6):837–840. doi: 10.1136/gut.35.6.837

Effect of omeprazole and sucralfate on prepyloric gastric ulcer. A double blind comparative trial and one year follow up.

H T Sørensen 1, H H Rasmussen 1, I Balslev 1, S Boesby 1, J Boné 1, A Kruse 1, S N Rasmussen 1
PMCID: PMC1374890  PMID: 8020815

Abstract

This study compared healing rates, relief of symptoms, frequency of adverse events, and proportion of patients in remission after one year follow up in 104 patients with active prepyloric ulcer during treatment with 40 mg omeprazole once daily or 2 g sucralfate twice daily, using a randomised double blind controlled trial. Healing rates after two, four, and six weeks were (omeprazole/sucralfate) 49%/23%; 83%/59%; 90%/70% respectively. After two weeks, omeprazole was more efficient than sucralfate in relief of daytime and nocturnal epigastric pain, nausea, and heartburn. The proportion of patients in remission after one year follow up was significantly higher in the omeprazole group (p < 0.01). Of the healed patients ulcers recurred in 36% in the omeprazole group and in 46% in the sucralfate group. It is concluded that the ulcer healing rate was higher and symptom relief was more pronounced in the omeprazole group compared with the sucralfate group, and that more patients were still in remission after a one year follow up period.

Full text

PDF
837

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Binder H. J., Cocco A., Crossley R. J., Finkelstein W., Font R., Friedman G., Groarke J., Hughes W., Johnson A. F., McGuigan J. E. Cimetidine in the treatment of duodenal ulcer: a multicenter double blind study. Gastroenterology. 1978 Feb;74(2 Pt 2):380–388. [PubMed] [Google Scholar]
  2. Frost F., Rahbek I., Rune S. J., Jensen K. B., Gudmand-Hoyer E., Krag E., Rask-Madsen J., Wulff H. R., Garbol J., Jensen K. G. Cimetidine in patients with gastric ulcer: a multicentre controlled trial. Br Med J. 1977 Sep 24;2(6090):795–797. doi: 10.1136/bmj.2.6090.795. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Lam S. K. Why do ulcers heal with sucralfate? Scand J Gastroenterol Suppl. 1990;173:6–16. doi: 10.3109/00365529009091918. [DOI] [PubMed] [Google Scholar]
  4. Lauritsen K., Rune S. J., Wulff H. R., Olsen J. H., Laursen L. S., Havelund T., Astrup L., Bendtsen F., Linde J., Bytzer P. Effect of omeprazole and cimetidine on prepyloric gastric ulcer: double blind comparative trial. Gut. 1988 Feb;29(2):249–253. doi: 10.1136/gut.29.2.249. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. McTavish D., Buckley M. M., Heel R. C. Omeprazole. An updated review of its pharmacology and therapeutic use in acid-related disorders. Drugs. 1991 Jul;42(1):138–170. doi: 10.2165/00003495-199142010-00008. [DOI] [PubMed] [Google Scholar]
  6. Morgan T. M. Analysis of duration of response: a problem of oncology trials. Control Clin Trials. 1988 Mar;9(1):11–18. doi: 10.1016/0197-2456(88)90004-9. [DOI] [PubMed] [Google Scholar]
  7. O'Brien P. C., Fleming T. R. A multiple testing procedure for clinical trials. Biometrics. 1979 Sep;35(3):549–556. [PubMed] [Google Scholar]
  8. Tytgat G. N. Future potential applicability of sucralfate in gastroenterology. Scand J Gastroenterol Suppl. 1990;173:34–38. doi: 10.3109/00365529009091921. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES